Search Results 571-580 of 17026 for pharmacogenetics
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the study is to compare sacituzumab tirumotecan combined with ...
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can ...
About this study. The purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, ...
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
Genetic Variations May Help Identify Best Candidates for Preventive Breast Cancer Drugs. ROCHESTER, Minn. — Newly discovered genetic variations may help ...
Rochester, Minn. The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation ...
See information about research education and training opportunities in Mayo Clinic's Department of Molecular Pharmacology and Experimental Therapeutics.
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...
About this study. The goal of this study is to provide longitudinal data on the efficacy of cognitive behavior- based interdisciplinary pain rehabilitation ...
Daniel J. Schaid, Ph.D., is a professor of biostatistics at Mayo Clinic who researches statistical methods and data for genetic studies on breast cancer, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.